Trade JnJ ^JNJ

IBM, Johnson & Johnson Defeat Lawsuit Over 2023 Data Incident

PepsiCo (PEP) Welcomes Johnson & Johnson's Joaquin Duato to Board of Directors - Blockonomi

'AI safety requires immediate action': House Dems demand Johnson cancel recess & take up safeguards - The Economic Times Video | ET Now

Promising Healthcare Stocks To Follow Today - September 18th - Stock Observer

JNJ Announces CHMP's Recommendation For Approval Of TECVAYLI

Johnson & Johnson (JNJ) Advances Sjögren's Therapies With New Biomarker Trial Data - Simply Wall St News

Johnson & Johnson (JNJ) Faces A Fresh Valuation Test On DePuy Sale Talk

Johnson & Johnson $JNJ Shares Sold by Smith Chas P & Associates PA Cpas

Nykredit A S Takes $235.82 Million Position in Johnson & Johnson $JNJ

PepsiCo appoints J&J CEO Joaquin Duato to its board

Apollo Global Management (APO) Eyes DePuy Synthes While Adding $5.5 Billion In Auto Loans

CHMP recommends approval of Johnson & Johnson's TECVAYLI®▼ (teclistamab) in relapsed/refractory multiple myeloma after at least one prior therapy | Valuespectrum.com

PepsiCo names Joaquin Duato to Board of Directors

Johnson & Johnson (NYSE:JNJ) Trading 1.3% Higher - Still a Buy?

Top Pharmaceutical Stocks Worth Watching - September 17th - Markets Daily

Altis Labs' AI software detected treatment benefit earlier in oncology trial

Johnson & Johnson Sees Path to Double-Digit Growth Despite 2026 Patent Cliff - Stock Observer

The Manufacturers Life Insurance Company Has $951.49 Million Stock Position in Johnson & Johnson $JNJ

Van Hulzen Asset Management LLC Has $30.19 Million Stake in Johnson & Johnson $JNJ

Core Capital Management & Research inc. Buys Shares of 4,002 Johnson & Johnson $JNJ

Archford Capital Strategies LLC Has $10.32 Million Stock Holdings in Johnson & Johnson $JNJ

Color patterns as a model for connecting developmental mechanisms to phenotypic evolution

J&J Slips as Caplyta Clears a Quality-of-Life Test

Should You Judge JNJ Stock Without STELARA?

Monthly Paydays vs. Compound Growth: Why JNJ Beats O for Long-Term Retirees

Abiomed Gets Benefit Plan Exemption for Johnson & Johnson Deal

Best Healthcare Stocks To Follow Today - September 16th - Stock Observer

Will Your Organization Stand By Its Values-Even When It's Hard?

Johnson & Johnson $JNJ Shares Sold by HighTower Advisors LLC

Waverly Advisors LLC Buys 42,556 Shares of Johnson & Johnson $JNJ

HORAN Wealth LLC Decreases Stock Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Bought by Arizona State Retirement System

Anchor Capital Advisors LLC Sells 5,801 Shares of Johnson & Johnson $JNJ

Amundi Decreases Stock Position in Johnson & Johnson $JNJ

Allworth Financial LP Sells 49,306 Shares of Johnson & Johnson $JNJ

Epidemiology, mechanisms and clinical implications of heat-related kidney disease

Johnson & Johnson Partner Contineum Slides as Depression Drug Fails

Apollo and J&J Face a High-Stakes Orthopedics Deal

From Coca-Cola to OpenAI, Brands Are Betting Bigger on OOH

Companies Push for Litigation Funding Disclosure: Delaware Brief

3 Dividend Stocks Baby Boomers Should Own for the Rest of Their Lives

Johnson & Johnson $JNJ Shares Purchased by Groupe la Francaise

Saudi Central Bank Increases Stock Position in Johnson & Johnson $JNJ

VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $207.87 Million Investment in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Acquired by Ameritas Advisory Services LLC

The Global Expansion Narrative of Chinese Innovative Drugs: A Game-Changing Development Set to Unfold in Two Weeks

JNJ Q3 2026 Earnings Report on 10/13/2026

Rep. Thomas H. Kean, Jr. Sells Off Johnson & Johnson (NYSE:JNJ) Shares

Contineum's Phase 2 MOONLIGHT-1 Trial Misses Primary Endpoint In MDD; Stock Down

RYBREVANT FASPRO plus LAZCLUZE® with prophylactic strategies shows low rates of treatment-related events at WCLC 2026 | INN

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint | Morningstar

Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder | Morningstar

Apollo rumoured to be eyeing $20bn takeover of J&J's orthopaedics business

Johnson & Johnson Shares Rise on Reported Apollo Talks for Orthopedics Unit

Top Pharmaceutical Stocks To Research - September 14th - Daily Political

Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition - Daily Political

J&J's RYBREVANT Plus Chemotherapy Sets New Benchmark In EGFR Exon 20 Insertion NSCLC Survival

Zacks Investment Ideas feature highlights: Johnson & Johnson, Coca-Cola and Exxon Mobil

Compass Financial Management LLC Invests $1.42 Million in Johnson & Johnson $JNJ

Bank of America Corp DE Sells 2,078,556 Shares of Johnson & Johnson $JNJ

Azimuth Capital Investment Management LLC Sells 3,870 Shares of Johnson & Johnson $JNJ

Pharmaceutical Stocks To Keep An Eye On - September 13th - Daily Political

Johnson & Johnson $JNJ Shares Bought by Concurrent Investment Advisors LLC

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind

Pharmaceutical Stocks To Follow Today - September 12th - Stock Observer

PYA Waltman Capital LLC Has $11.44 Million Position in Johnson & Johnson $JNJ - Markets Daily

Burford Brothers Inc. Decreases Stake in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Stock Holdings Lifted by PYA Waltman Capital LLC - Stock Observer

Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage - Stock Observer

J&J orthopedics unit draws Apollo interest in potential $20 billion deal: Report - The Economic Times

Apollo Global in talks to buy J&J's orthopedics unit, Bloomberg reports

Apollo Global Is Said in Talks to Acquire J&J's Orthopedics Unit

Is AbbVie Stock Actually Overpriced?

Meet Ottava, J&J's surgical robot leading the healthcare giant into a lucrative new market

3 Top Dividend Aristocrats To Own Near All-Time Highs

Johnson & Johnson (NYSE:JNJ) Receives Consensus Rating of "Moderate Buy" from Brokerages - Zolmax

J&J's new reusable contact lens secures CE Mark

Rinkey Investments Reduces Holdings in Johnson & Johnson $JNJ

Proficio Capital Partners LLC Boosts Position in Johnson & Johnson $JNJ

Proficio Capital Partners LLC Increases Stock Position in Johnson & Johnson $JNJ - Markets Daily

Lone Peak Global Investors LLC Decreases Holdings in Johnson & Johnson $JNJ

New Technologies and Achievements Make Concentrated Debuts, Highlighting CIFTIS as a Platform for Innovation | AsiaNet

RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

Johnson & Johnson $JNJ Shares Sold by XML Financial LLC - Daily Political

Rinkey Investments Cuts Stake in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson Receives CE Marking For ACUVUE OASYS MAX 2-Week Contact Lenses

J&J names two-decade veteran as chief IP counsel | Careers | Life Sciences Intellectual Property Review

J&J unit win shuts door on Sandoz generic launch | Pharma | Life Sciences Intellectual Property Review

Johnson & Johnson $JNJ Shares Sold by Meiji Yasuda Life Insurance Co - Zolmax

Northwestern Mutual Wealth Management Co. Has $93.80 Million Stock Holdings in Johnson & Johnson $JNJ - Zolmax

Nichols & Pratt Advisers LLP MA Lowers Holdings in Johnson & Johnson $JNJ

Montanova Capital LLC Has $1.96 Million Position in Johnson & Johnson $JNJ

Sigma Planning Corp Boosts Stock Holdings in Johnson & Johnson $JNJ

Gold Price Forecast 2026, 2027 and 2030: Can Gold Hold $4,200 After the Fed’s First Rate Hike Since 2023?

Fed Interest Rate Forecast 2026: Will the Fed Raise Rates Again?

Japan could be heading for another historic rate move.

Tesla Stock Forecast 2026 & 2030: Can TSLA Reach $1,000?

UK August inflation & the Fed rate decision

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

WTI Slides Below $100 as Saudi Supply Recovery Hopes Ease Market Fears

Nasdaq 100 Futures Rise as Oil Pullback and Tech Rally Ease Fed Rate-Hike Pressure

Sandisk Stock Jumps 6% as AI Memory Rally and Long-Term Contracts Lift Sentiment

Gold Price Today: Gold Holds Near $4,350 as Lower Oil Prices and Treasury Yields Support Recovery

UBS Sees Gold at $5,400 by 2027 Despite Hawkish Fed Rate Hike

GBP/USD Holds Near Six-Week Low Around 1.34 After Hawkish Fed and BoE Rate Hold

BOJ Raises Rates to 1.25%: Can the Yen Push USD/JPY Below 155?

Meta Stock Rises 10% After Muse AI Launch: Can META Reach Citi’s $800 Target?